US Lymphedema Market Size By Cause (Cancer, CVI), By Age Group (Below 18, Above 65 Years), By Therapy (Controlled Compression Therapy, Manual Lymph Drainage (MLD)), By End User (Hospitals, Clinics) And Forecast

US Lymphedema Market Size And Forecast

US Lymphedema Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2021 to 2028.

The rise in the number of lymphedema cases in the US is a prominent factor driving the growth of the US Lymphedema Market. The US Lymphedema Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

US Lymphedema Market Definition

Lymphedema is a condition in which an overabundance of lymph fluid builds up in tissues, causing swelling. If lymph vessels are obstructed, injured, or eliminated during surgery, it might happen in an arm or leg. However, Lymphoma and lymphatic illnesses affect up to ten million Americans and hundreds of millions. In the United States, these diseases affect more individuals than Multiple Sclerosis, Muscular Dystrophy, ALS, Parkinson’s disease, and AIDS combined. Lymphoma can affect anybody who has had cancer therapy, including individuals who have had melanoma, prostate cancer, or ovarian cancer.

Breast cancer survivors are at a higher risk of getting lymphedema, and 100 percent of people who have had neck or head cancer will acquire it. Lymphoma, a common source of lymphatic illness among our injured warriors, can also be caused by physical trauma. Additionally, Lymphedema can be primary or secondary. The improper development of the lymph system causes primary lymphedema. Symptoms might appear at any time during life, including at birth. Damage to the lymphatic system causes secondary lymphedema. Infection, injury, cancer, lymph node excision, radiation to the afflicted region, or scar tissue following radiation therapy or surgery can all harm or clog the lymph system.

Lymphedema can develop as a result of any malignancy or therapy that disrupts lymph flow through the lymph nodes, such as lymph node excision. It might appear days after therapy or years afterward. Within three years after surgery, the majority of patients develop lymphedema. The following are some of the risk factors for lymphedema Lymph nodes in the underarm, groin, pelvis, or neck are removed and/or radiated. The number of lymph nodes impacted raises the risk of lymphedema. Only removing the sentinel lymph node has a lower risk (the first lymph node in a group of lymph nodes to receive lymphatic drainage from the primary tumor).

US Lymphedema Market Overview

Because of the growing incidence of lymphedema in countries such as the United States and Canada, which is related to the increased occurrence of breast cancer in these nations, North America is likely to lead the US Lymphedema Market in the future years. The presence of certain major companies in the US Lymphedema Market in the United States and Canada such as Tactile Systems Technology Inc. and Bio Compression System is projected to have a beneficial influence on this region’s lymphedema treatment industry.

Furthermore, major key players working on the development of new innovative medical devices which can be easily used at home to cure lymphedema. For instance, in September 2021, Tactile Systems Technology, Inc. specialized in the development of medical devices for the home treatment of chronic conditions. The first patient in a randomized, controlled clinical trial testing the effectiveness of its FlexTouch Plus technology for the treatment of head and neck lymphedema has been enrolled.

US Lymphedema MarketSegmentation Analysis

The US Lymphedema Market is Segmented on the basis of Cause, Age Group, Therapy, And End User.

US Lymphedema Market, By Cause

• Cancer
• CVI
• Surgery
• Trauma
• Others

Based on Cause, the market is bifurcated into Cancer, CVI, Surgery, Trauma, And Others. Cancer causes stakes a major share in the development of the US Lymphedema Market owing to the increased number of cancer patients such as breast cancer and another type of cancer.

US Lymphedema Market, By Age Group

• Below 18
• 18-44 years
• 45- 65 years
• Above 65 years

Based on Age Group, the market is segregated into 18-44 years, 45- 65 years, and above 65 years. The below 18 segment mainly suffers from Primary lymphedema and it is generally the result of an error in the development of the lymphatic system. Secondary lymphedema represents more than 99% of the total cases. It occurs in adults above the age of 30 due to cancer treatment or surgery, which results in the removal of lymph nodes.

US Lymphedema Market, By Therapy

• Controlled Compression Therapy
• Manual Lymph Drainage (MLD)
• Complete Decongestive Therapy (CDT)
• Pneumatic Compression (PC)

Based on Therapy, the market is segmented into Controlled Compression Therapy, Manual Lymph Drainage (MLD), Complete Decongestive Therapy (CDT), And Pneumatic Compression (PC). Controlled compression therapy has a major share compared with other types of therapy in the US Lymphedema Market owing to it efficiently controlling illness symptoms.

US Lymphedema Market, By End User

• Hospitals
• Clinics
• Clinical research organization
• Others

Based on End User, the US Lymphedema Market is categorized into hospitals, clinics, clinical research organizations (CROs), and others.

Key Players

The “US Lymphedema Market” study report will provide valuable insight with an emphasis on the US market including some of the major players such as Tactile Systems Technology Inc., Bio Compression System, Lympha Press (Mego Afek), Essity (BSN Medical), Sigvaris, and others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players.

Key Developments

• In September 2021, Tactile Systems Technology, Inc. has acquired the assets of International Biophysics Corporation, which developed and manufactured the AffloVest respiratory treatment device.
• In August 2018, SIGVARIS has announced the availability of new COMPREFLEX REDUCE accessories and upgrades. The new COMPREFLEX REDUCE is the most advanced compression device for use during the decongestive phase of lymphedema therapy because of these additional characteristics.
• In September 2018, SIGVARIS has introduced SECURE, an innovative garment with progressive compression and containment features for advanced venous edema, lymphedema, post-surgical edema, and general edema treatment.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.